Robot-assisted partial nephrectomy for totally intrarenal tumors: a single surgeon's experience
10.3760/cma.j.issn.1000-6702.2018.06.005
- VernacularTitle:单术者机器人辅助腹腔镜肾部分切除术治疗完全内生型肾肿瘤38例临床分析
- Author:
Jiazi SHI
1
;
Chengzong LIU
;
Weiping WANG
;
Yi DONG
;
Wanting ZANG
;
Zhenjie WU
;
Bing LIU
;
Linhui WANG
Author Information
1. 200003,上海长征医院泌尿外科
- Keywords:
Kidney neoplasms;
Partial nephrectomy;
Totally intrarenal tumors;
Robot
- From:
Chinese Journal of Urology
2018;39(6):419-421
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the safety and efficiency of robot-assisted partial nephrectomy (RAPN) for totally intrarenal tumors (TITs).Methods Thirty-eight patients who underwent RAPN for treating TITs by one experienced surgeon were included between August 2012 and December 2017.There were 25 males and 13 females,aged 26-72 years(mean 51.6 years).Tumors of 24 cases were in right kidney,and 14 cases in left kidney.The diameter of tumor was(3.12 ± 0.92) cm,the R.E.N.A.L.score was(9.76 ± 1.00),and the Scr was (74.82 ± 20.32) μmol/L.Patients' peri-operative and oncological outcomes were analyzed.Results All the tumors were successfully resected without conversion to open surgery or radical nephrectomy.Mean operative time and ischemia time were (188.47 ± 46.75) min and (24.32 ± 7.69) min.Mean blood loss was (115.79 ± 43.66) rrd.One-week postoperative Scr was (85.97 ± 28.33) μmol/L.Postoperative hemorrhage was successfully treated by DSA or drug therapy in 3 patients.The pathological examination showed 28 clear cell renal cell carcinomas,3 chromophobe renal cell carcinomas,3 TFE-3 infusion related renal cell carcinomas,2 metanephric adenomas,1 acidophile adenoma and 2 angioleiomyolipomas.One positive surgical margin occurred in RAPN group for cystic components.No evidence of tumor progression observed during follow-up.Conclusions RAPN is safe and effective in treating TITs when performed by an experienced surgeon at a high-volume institution.Further prospective and large-scale study was warranted to evaluate the long-term outcomes.
